The Promise of Novel Biomarkers for Head and Neck Cancer from an Imaging Perspective

International Journal of Molecular Sciences

Eva Bezak¹  Paul Reid¹  LoredanaG. Marcu² 

[1] Cancer Research Institute and School of Health Sciences, University of South Australia, Adelaide, SA 5001, Australia;Faculty of Science, University of Oradea, 410087 Oradea, Romania;

关键词: hypoxia;    proliferation;    cancer stem cells;    radioresistance;    PET;    SPECT;    MRI;   

DOI  :  10.3390/ijms19092511

来源: DOAJ

【 摘 要 】

It is an agreed fact that overall survival among head and neck cancer patients has increased over the last decade. Several factors however, are still held responsible for treatment failure requiring more in-depth evaluation. Among these, hypoxia and proliferation-specific parameters are the main culprits, along with the more recently researched cancer stem cells. This paper aims to present the latest developments in the field of biomarkers for hypoxia, stemness and tumour proliferation, from an imaging perspective that includes both Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) as well as functional magnetic resonance imaging (MRI). Quantitative imaging of biomarkers is a prerequisite for accurate treatment response assessment, bringing us closer to the highly needed personalised therapy.

【 授权许可】

Unknown